A few AH snips | Biotech Message Board Posts

Biotech   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  29794 of 30915  at  2/18/2020 5:25:19 PM  by

minxmrphd


A few AH snips

 

$RETA Jefferies raises PT to $333 ahead of Q4 update. Anticipates incremental updates related to bard and omav regulatory filings, potential APDKD status update and some tidbits on upcoming phase 3 CTD-PAH readout

$ARNA –particularly undervalued (particularly considering cash equivalents are ~$1.2B) stock as most attractive to holders with a time horizon that extends through at least YE21. In our view, S1Ps will be an attractive drug class for ulcerative colitis and other diseases

JPMorgan raises PT for $CCXI to $60, keeps an Overweight rating

$XAIR has about 20% insider ownership & most of shares bought on the market over past year with broad insider purchases in June PIPE & December. There were very few windows to buy & whenever there is they buy aggressively.

$BLPH H.C. Wainwright Buy Rating PT $30

CS $ESPR approval widely expected



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 9     Views: 158
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...